CANC ETF
Tema Oncology ETF
RVMD is CANC's largest holding at 5.58% of the fund as of Oct 1, 2026. CANC is Tema Oncology ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | R | Revolution Medicines Inc Ser C Pc PpHealth Care · Biotechnology | 5.58% | 5.6% | 55,664 | $11.46M | Health Care | Biotechnology |
| 2 | M | Merck & Company IncHealth Care · Pharmaceuticals | 4.86% | 10.4% | 69,423 | $9.98M | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | C | Cogent Biosciences Inc | 4.73% | 15.2% | 307,451 | $9.71M | ||
| 4 | L | Eli Lilly & Co. | 4.60% | 19.8% | 8,209 | $9.44M | ||
| 5 | N | Novartis Ag - | 3.71% | 23.5% | 53,535 | $7.61M | ||
| 6 | B | Bristol-Myers Squibb Co. | 3.45% | 26.9% | 115,234 | $7.08M | ||
| 7 | A | AbbVie Inc. | 3.34% | 30.3% | 26,349 | $6.85M | ||
| 8 | B | BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary) | 3.33% | 33.6% | 19,049 | $6.83M | ||
| 9 | I | Iovance Biotherapeutics Inc | 3.24% | 36.8% | 467,476 | $6.65M | ||
| 10 | — | Genmab A/s ADR | 3.15% | 40.0% | 187,107 | $6.46M | ||
| 11 | E | Exelixis Inc | 3.12% | 43.1% | 110,600 | $6.41M | ||
| 12 | H | Halozyme Therapeutics Inc | 3.05% | 46.2% | 58,493 | $6.26M | ||
| 13 | R | Roche Holding Ag (Adr) | 3.05% | 49.2% | 119,440 | $6.25M | ||
| 14 | J | Johnson & Johnson - | 2.95% | 52.2% | 23,415 | $6.06M | ||
| 15 | I | Ideaya Biosciences Inc | 2.67% | 54.8% | 145,181 | $5.49M | ||
| 16 | C | Cg Oncology Inc | 2.63% | 57.5% | 79,127 | $5.41M | ||
| 17 | B | Bridgebio Pharma Inc_None_0 | 2.41% | 59.9% | 73,889 | $4.94M | ||
| 18 | I | Immunome Inc | 2.40% | 62.3% | 235,688 | $4.92M | ||
| 19 | E | Enliven Therapeutics Inc | 2.32% | 64.6% | 103,107 | $4.76M | ||
| 20 | — | AstraZeneca PLC | 2.05% | 66.6% | 26,513 | $4.21M | ||
| 21 | Z | Zai Lab Ltd | 2.04% | 68.7% | 164,578 | $4.20M | ||
| 22 | R | Relay Therapeutics Inc | 2.02% | 70.7% | 224,406 | $4.15M | ||
| 23 | E | Erasca Inc. | 1.91% | 72.6% | 269,242 | $3.93M | ||
| 24 | L | Legend Biotech Corp-adr | 1.90% | 74.5% | 201,984 | $3.90M | ||
| 25 | C | Celcuity Inc | 1.60% | 76.1% | 43,707 | $3.28M | ||
| 26 | — | Zymeworks Inc. | 1.43% | 77.5% | 112,869 | $2.93M | ||
| 27 | S | Summit Therapeutics | 1.42% | 79.0% | 174,626 | $2.91M | ||
| 28 | A | Amgen Inc. | 1.30% | 80.3% | 6,542 | $2.66M | ||
| 29 | U | Urogen Pharma Ltd Com Ils0.01 | 1.24% | 81.5% | 62,529 | $2.54M | ||
| 30 | N | Natera Inc | 1.23% | 82.7% | 6,204 | $2.53M | ||
| 31 | N | Nuvation Bio Inc | 1.15% | 83.9% | 425,168 | $2.36M | ||
| 32 | K | Kura Oncology Inc | 1.11% | 85.0% | 214,774 | $2.29M | ||
| 33 | R | Arcus Biosciences Inc | 1.09% | 86.1% | 88,847 | $2.24M | ||
| 34 | G | Gilead Sciences | 1.07% | 87.2% | 14,946 | $2.20M | ||
| 35 | A | Anaptysbio Inc | 0.79% | 87.9% | 33,414 | $1.62M | ||
| 36 | C | Corvus Pharmaceuticals Inc | 0.78% | 88.7% | 145,642 | $1.59M | ||
| 37 | G | Guardant Health, Inc | 0.76% | 89.5% | 8,943 | $1.56M | ||
| 38 | I | Immatics N.V. Ordinary Shares | 0.75% | 90.2% | 183,297 | $1.55M | ||
| 39 | F | First Am Treas Obli-X | 0.73% | 91.0% | 1,503,009 | $1.50M | ||
| 40 | R | Replimune Group Inc | 0.72% | 91.7% | 110,633 | $1.49M | ||
| 41 | I | Inhibrx Biosciences Inc | 0.69% | 92.4% | 14,407 | $1.41M | ||
| 42 | O | Oric Pharmaceuticals, Inc. Series C | 0.69% | 93.1% | 113,079 | $1.42M | ||
| 43 | — | Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share | 0.68% | 93.7% | 45,820 | $1.40M | ||
| 44 | T | Tango Therapeutics Inc. | 0.68% | 94.4% | 56,944 | $1.39M | ||
| 45 | — | Moderna therapeutics | 0.58% | 95.0% | 6,301 | $1.19M | ||
| 46 | A | Amani Gold Ltd | 0.58% | 95.6% | 75,283 | $1.19M | ||
| 47 | A | Arrivent Biopharma Inc | 0.51% | 96.1% | 36,186 | $1.05M | ||
| 48 | — | Cullinan Oncology Inc | 0.48% | 96.6% | 67,125 | $975.3K | ||
| 49 | J | Janux Therapeutics Inc | 0.45% | 97.0% | 55,053 | $933.7K | ||
| 50 | C | Candel Therapeutics Inc. | 0.44% | 97.5% | 88,097 | $895.1K | ||
| More holdings · Pro | ||||||||
CANC ETF All Holdings
CANC holdings total 118 positions. The top 10 holdings account for 40.0% of the fund, led by Revolution Medicines Inc Ser C Pc Pp at 5.6%, Merck & Company Inc at 4.9%, Cogent Biosciences Inc at 4.7%.
CANC portfolio concentration is moderate, with the top 10 representing 40.0% of total assets. The largest sector exposure is Health Care at 89.8%.
CANC sectors provide a detailed breakdown. CANC overlap shows how holdings compare to other funds in your portfolio.
CANC ETF Holdings
61 of 118 holdings
- 1
Revolution Medicines Inc Ser C Pc Pp
RVMDHealth Care5.58% - 2
Merck & Company Inc
MRKHealth Care4.86% - 3
Cogent Biosciences Inc
COGTHealth Care4.73% - 4
Eli Lilly & Co.
LLYHealth Care4.60% - 5
Novartis Ag - Common
NOVN:SMUnknown3.71% - 6
Bristol-Myers Squibb Co.
BMYHealth Care3.45% - 7
Abbvie Inc.
ABBVHealth Care3.34% - 8
BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary)
BGNE:SHHealth Care3.33% - 9
Iovance Biotherapeutics Inc
IOVAHealth Care3.24% - 10
Genmab A/s ADR
GMAB:COHealth Care3.15% - 11
Exelixis Inc
EXELHealth Care3.12% - 12
Halozyme Therapeutics Inc
HALOHealth Care3.05% - 13
Roche Holding Ag (Adr)
RHHBY:SMUnknown3.05% - 14
Johnson & Johnson - Common
JNJHealth Care2.95% - 15
Ideaya Biosciences Inc
IDYAHealth Care2.67% - 16
Cg Oncology Inc
CGONHealth Care2.63% - 17
Bridgebio Pharma Inc_None_0
BBIOHealth Care2.41% - 18
Immunome Inc
IMNMHealth Care2.40% - 19
Enliven Therapeutics Inc
ELVNHealth Care2.32% - 20
AstraZeneca PLC
AZN:LNUnknown2.05% - 21
Zai Lab Ltd
ZLABHealth Care2.04% - 22
Relay Therapeutics Inc
RLAYHealth Care2.02% - 23
Erasca Inc.
ERASHealth Care1.91% - 24
LEGEND BIOTECH CORP-ADR
LEGNHealth Care1.90% - 25
Celcuity Inc Com
CELCHealth Care1.60% - 26
Zymeworks Inc. Common Stock
ZYME:CAHealth Care1.43% - 27
Summit Therapeutics
SMMTHealth Care1.42% - 28
Amgen Inc.
AMGNHealth Care1.30% - 29
Urogen Pharma Ltd Com Ils0.01
URGNHealth Care1.24% - 30
Natera Inc
NTRAHealth Care1.23% - 31
Nuvation Bio Inc
NUVBHealth Care1.15% - 32
Kura Oncology Inc
KURAHealth Care1.11% - 33
Arcus Biosciences Inc
RCUSHealth Care1.09% - 34
Gilead Sciences
GILDHealth Care1.07% - 35
Anaptysbio Inc
ANABHealth Care0.79% - 36
Corvus Pharmaceuticals Inc
CRVSHealth Care0.78% - 37
Guardant Health, Inc
GHHealth Care0.76% - 38
Immatics N.V. Ordinary Shares
4A3:BEHealth Care0.75% - 39
First Am Treas Obli-X
FXFXXFinancials0.73% - 40
Replimune Group Inc Com
REPLHealth Care0.72% - 41
Inhibrx Biosciences Inc
INBXHealth Care0.69% - 42
Oric Pharmaceuticals, Inc. Series C
ORICHealth Care0.69% - 43
Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share
IMCR:LNHealth Care0.68% - 44
Tango Therapeutics Inc.
TNGXHealth Care0.68% - 45
Moderna therapeutics
MRNAHealth Care0.58% - 46
Amani Gold Ltd
ANL:AUUnknown0.58% - 47
ARRIVENT BIOPHARMA INC
AVBPHealth Care0.51% - 48
Cullinan Oncology Inc
CGEMHealth Care0.48% - 49
Janux Therapeutics Inc
JANXHealth Care0.45% - 50
Candel Therapeutics Inc.
CADLHealth Care0.44% - 51
Twist Bioscience Corp.
TWSTHealth Care0.35% - 52
Bicara Therapeutics, Inc.
BCAXHealth Care0.34% - 53
Olema Pharmaceuticals Inc
OLMAHealth Care0.34% - 54
Arvinas Inc
ARVNHealth Care0.33% - 55
Cytomx Therapeutics Inc
CTMXHealth Care0.32% - 56
Tyra Biosciences Inc
TYRAHealth Care0.30% - 57
Verastem Inc Common Stock Usd.0001
VSTMHealth Care0.26% - 58
Autolus Therapeutics Ltd. Adr
AUTL:LNHealth Care0.25% - 59
BRIDGEBIO ONCOLOGY THERAPEUTICS IN
BBOTUnknown0.12% - 60
Swiss Franc
Other0.08% - 61
Us Dollar
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc Ser C Pc Pp | RVMD | 5.580% | ||
| 2 | Merck & Company Inc | MRK | 4.860% | ||
| 3 | Cogent Biosciences Inc | COGT | 4.730% | ||
| 4 | Eli Lilly & Co. | LLY | 4.600% | ||
| 5 | Novartis Ag - Common | NOVN:SM | 3.710% | ||
| 6 | Bristol-Myers Squibb Co. | BMY | 3.450% | ||
| 7 | Abbvie Inc. | ABBV | 3.340% | ||
| 8 | BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary) | BGNE:SH | 3.330% | ||
| 9 | Iovance Biotherapeutics Inc | IOVA | 3.240% | ||
| 10 | Genmab A/s ADR | GMAB:CO | 3.150% | ||
| 11 | Exelixis Inc | EXEL | 3.120% | ||
| 12 | Halozyme Therapeutics Inc | HALO | 3.050% | ||
| 13 | Roche Holding Ag (Adr) | RHHBY:SM | 3.050% | ||
| 14 | Johnson & Johnson - Common | JNJ | 2.950% | ||
| 15 | Ideaya Biosciences Inc | IDYA | 2.670% | ||
| 16 | Cg Oncology Inc | CGON | 2.630% | ||
| 17 | Bridgebio Pharma Inc_None_0 | BBIO | 2.410% | ||
| 18 | Immunome Inc | IMNM | 2.400% | ||
| 19 | Enliven Therapeutics Inc | ELVN | 2.320% | ||
| 20 | AstraZeneca PLC | AZN:LN | 2.050% | ||
| 21 | Zai Lab Ltd | ZLAB | 2.040% | ||
| 22 | Relay Therapeutics Inc | RLAY | 2.020% | ||
| 23 | Erasca Inc. | ERAS | 1.910% | ||
| 24 | LEGEND BIOTECH CORP-ADR | LEGN | 1.900% | ||
| 25 | Celcuity Inc Com | CELC | 1.600% | ||
| 26 | Zymeworks Inc. Common Stock | ZYME:CA | 1.430% | ||
| 27 | Summit Therapeutics | SMMT | 1.420% | ||
| 28 | Amgen Inc. | AMGN | 1.300% | ||
| 29 | Urogen Pharma Ltd Com Ils0.01 | URGN | 1.240% | ||
| 30 | Natera Inc | NTRA | 1.230% | ||
| 31 | Nuvation Bio Inc | NUVB | 1.150% | ||
| 32 | Kura Oncology Inc | KURA | 1.110% | ||
| 33 | Arcus Biosciences Inc | RCUS | 1.090% | ||
| 34 | Gilead Sciences | GILD | 1.070% | ||
| 35 | Anaptysbio Inc | ANAB | 0.790% | ||
| 36 | Corvus Pharmaceuticals Inc | CRVS | 0.780% | ||
| 37 | Guardant Health, Inc | GH | 0.760% | ||
| 38 | Immatics N.V. Ordinary Shares | 4A3:BE | 0.750% | ||
| 39 | First Am Treas Obli-X | FXFXX | 0.730% | ||
| 40 | Replimune Group Inc Com | REPL | 0.720% | ||
| 41 | Inhibrx Biosciences Inc | INBX | 0.690% | ||
| 42 | Oric Pharmaceuticals, Inc. Series C | ORIC | 0.690% | ||
| 43 | Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share | IMCR:LN | 0.680% | ||
| 44 | Tango Therapeutics Inc. | TNGX | 0.680% | ||
| 45 | Moderna therapeutics | MRNA | 0.580% | ||
| 46 | Amani Gold Ltd | ANL:AU | 0.580% | ||
| 47 | ARRIVENT BIOPHARMA INC | AVBP | 0.510% | ||
| 48 | Cullinan Oncology Inc | CGEM | 0.480% | ||
| 49 | Janux Therapeutics Inc | JANX | 0.450% | ||
| 50 | Candel Therapeutics Inc. | CADL | 0.440% | ||
| 51 | Twist Bioscience Corp. | TWST | 0.350% | ||
| 52 | Bicara Therapeutics, Inc. | BCAX | 0.340% | ||
| 53 | Olema Pharmaceuticals Inc | OLMA | 0.340% | ||
| 54 | Arvinas Inc | ARVN | 0.330% | ||
| 55 | Cytomx Therapeutics Inc | CTMX | 0.320% | ||
| 56 | Tyra Biosciences Inc | TYRA | 0.300% | ||
| 57 | Verastem Inc Common Stock Usd.0001 | VSTM | 0.260% | ||
| 58 | Autolus Therapeutics Ltd. Adr | AUTL:LN | 0.250% | ||
| 59 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.120% | ||
| 60 | Swiss Franc | - | 0.080% | ||
| 61 | Us Dollar | - | 0.000% |











































